Stocklytics Platform
Asset logo for symbol BLTE
Belite Bio,
BLTE41
$55.53arrow_drop_up1.54%$0.84
Asset logo for symbol BLTE
BLTE41

$55.53

arrow_drop_up1.54%
Key Stats
Open$53.95
Prev. Close$54.69
EPS-1.10
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range53.63
55.53
52 Week Range28.51
86.14
Ratios
Revenue-
EBITDA Margin %-
EPS-1.10
Fundamentals
Gross Profit-
Total Debt-
Payout Ratio-
Industry average yield2.87%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

BLTE-
US Healthcare Sector-
US Market-
check_circle

BLTE / Market

BLTE exceeded the US Market which returned 1.27% over the last twenty four hours.
warning

BLTE / Healthcare Sector

BLTE lose to the US Healthcare sector which returned 2.39% over the last twenty four hours.

Belite Bio, (BLTE) Statistics

Belite Bio, Inc (BLTE) stock statistics provide valuable information about the company's performance in the financial markets. These statistics include various metrics that investors can use to evaluate the stock's potential. For instance, the valuation metrics help determine if the stock is trading at a fair price compared to its intrinsic value. Fundamental analysis is also crucial, as it examines the company's financial statements to assess its overall health and stability. By understanding these fundamentals, investors can make more informed decisions about buying or selling BLTE stock.
When analyzing the stock's performance against the sector, investors can gain insights into how BLTE is faring compared to its industry peers. This data sheds light on the company's relative strength and weakness within the sector, providing a broader context for evaluating its performance. Revenue per share is another important metric to consider, as it measures the company's ability to generate income for each outstanding share. A higher revenue per share indicates stronger financial performance.
add Belite Bio,  to watchlist

Keep an eye on Belite Bio,

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Belite Bio, (BLTE) stock's performance compared to its sector and the market over the past year?

Over the past year, Belite Bio, (BLTE) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 19.24%, Belite Bio, has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 34.38%, it has fallen short of the market average. This comparison highlights Belite Bio, 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Belite Bio, (BLTE) stock?

The PE ratio for Belite Bio, (BLTE) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Belite Bio, (BLTE) stock?

The Earnings Per Share (EPS) for Belite Bio, (BLTE), calculated on a diluted basis, is -$1.1. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Belite Bio, (BLTE) stock?

The operating margin for Belite Bio, (BLTE) is 0%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Belite Bio, (BLTE) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Belite Bio, (BLTE) is -$35.3M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Belite Bio, (BLTE) have?

The total debt for Belite Bio, (BLTE) is currently not available. The net debt for Belite Bio, (BLTE) is currently not available.

Take Your Investments to a Whole New Level